Clinical Trials Browser

Active not recruiting × Resectable Non-small Cell Lung Cancer × Pemetrexed × Clear all

NCT06161441 2026-01-12

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

Phase 2 Active not recruiting

Resectable Non-small Cell Lung Cancer